High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alberto S. Pappo, MD
Texas Children's Cancer Center
Principal Investigator - John M. Kirkwood, MD
UPMC Cancer Center at UPMC Presbyterian
Study Chair - Lawrence E. Flaherty, MD
Barbara Ann Karmanos Cancer Institute
Study Chair - Michael Smylie, MD, MB, ChB
Cross Cancer Institute at University of Alberta
Study Chair - Sanjiv S. Agarwala, MD
St. Luke's Cancer Network at St. Luke's Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
533 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Institute for Cancer Research at Westmead Hospital
Westmead, New South Wales, Australia
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Bcca - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Island Centre
Victoria, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Royal Victoria Hospital of Barrie
Barrie, Ontario, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- R. S. Mclaughlin Durham Regional Cancer Centre at Lakeridge Health Oshawa
Oshawa, Ontario, Canada
- St. Catharines General Hospital at Niagara Health System
St. Catharines, Ontario, Canada
- Edmond Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Trillium Health Centre - Mississauga Site
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre at Windsor Regional Hospital
Windsor, Ontario, Canada
- Chum - Hotel Dieu Hospital
Montreal, Quebec, Canada
- Hopital Notre-Dame Du Chum
Montreal, Quebec, Canada
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Pretoria Academic Hospital
Pretoria, South Africa
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente - Deer Valley
Antioch, California, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Kaiser Permanente - Fremont
Fremont, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Kaiser Permanente Medical Center - Hayward
Hayward, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Kaiser Permanente Medical Center - Oakland
Oakland, California, United States
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Kaiser Permanente Medical Center - Redwood City
Redwood City, California, United States
- Kaiser Permanente Medical Center - Richmond
Richmond, California, United States
- Kaiser Permanente Medical Center - Roseville
Roseville, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Mar 1999
- Primary completion
- 31 Jan 2015
- Completion
- 31 Dec 2026
- Last update posted
- 25 Feb 2026
- Registered enrollment
- 1,150
- Registry id
- NCT00003641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.